RoMEA Travel Vaccine Market to 2032
Overview
The RoMEA Travel Vaccine Market is expected to reach a 72.99 USD Million by 2032 and is projected to grow at a CAGR of 6.37% from 2025 to 2032.
Revenue, 2024 (USD Million)
49.22
Forecast, 2032 (USD Million)
72.99
CAGR, 2024 - 2032
6.37%
Report Coverage
RoMEA
RoMEA Travel Vaccine Market 2018-2032 USD Million
RoMEA Travel Vaccine Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 49.22 USD Million
- Projected Market Size (2032): 72.99 USD Million
- CAGR (2025-2032): 6.37%
Key Findings of RoMEA Travel Vaccine Market
- The RoMEA Travel Vaccine Market was valued at 49.22 USD Million in 2024.
- The RoMEA Travel Vaccine Market is likely to grow at a CAGR of 6.37% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 40.97 USD Million
- The fastest growing segment Typhoid in Disease Segment grew Fastest with a CAGR of 11.47% during the forecast period from 2024 to 2032.
RoMEA Travel Vaccine Market Scope
RoMEA Travel Vaccine Market Segmentation & Scope
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
RoMEA Travel Vaccine Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 49.22 USD Million |
| Market Value in 2032 | 72.99 USD Million |
| CAGR (2025-2032) | 6.37% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Disease,Category,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Type,Composition |
Regional Insights:
-
Leading Market (2024-2032): RoMEA, leading in terms of revenue 49.22 USD Million in 2024
- Key Country: RoMEA, leading in terms of revenue with value of 49.22 USD Million in 2024.
Segments and Scope
-
RoMEA Travel Vaccine Market to 2032, By Disease
- Typhoid is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 11.80 USD Million in the year 2024.
- Typhoid is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 11.47 % in forecast period 2025-2032.
-
RoMEA Travel Vaccine Market to 2032, By Category
- Recommended Vaccine is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 25.07 USD Million in the year 2024.
- Recommended Vaccine is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 6.73 % in forecast period 2025-2032.
-
RoMEA Travel Vaccine Market to 2032, By Distribution Channel
- B2B is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 38.97 USD Million in the year 2024.
- B2B is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 6.52 % in forecast period 2025-2032.
-
RoMEA Travel Vaccine Market to 2032, By Age Group
- 20-50 Years is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 26.46 USD Million in the year 2024.
- 20-50 Years is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 6.77 % in forecast period 2025-2032.
-
RoMEA Travel Vaccine Market to 2032, By Patient Type
- Adult is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 24.43 USD Million in the year 2024.
- Adult is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 6.92 % in forecast period 2025-2032.
-
RoMEA Travel Vaccine Market to 2032, By Gender
- Male is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 27.70 USD Million in the year 2024.
- Male is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 6.57 % in forecast period 2025-2032.
-
RoMEA Travel Vaccine Market to 2032, By Route of Administration
- Injectable is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 40.97 USD Million in the year 2024.
- Injectable is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 6.51 % in forecast period 2025-2032.
-
RoMEA Travel Vaccine Market to 2032, By Type
- Inactivated Vaccines is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 16.74 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 7.24 % in forecast period 2025-2032.
-
RoMEA Travel Vaccine Market to 2032, By Composition
- Combination Vaccines is the largest segment in RoMEA Travel Vaccine Market to 2032 with a revenue of 35.03 USD Million in the year 2024.
- Combination Vaccines is the Fastest growing segment in RoMEA Travel Vaccine Market to 2032 with a Growth rate of 6.51 % in forecast period 2025-2032.
RoMEA Travel Vaccine Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Pfizer Inc. | |||
| Sanofi | |||
| GSK plc. | |||
RoMEA Travel Vaccine Market Geographical Sales Distribution, 2018-2032 USD Million
RoMEA Travel Vaccine Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoMEA Travel Vaccine Market is segmented based on Segmentation Disease,Category,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Type,Composition.
RoMEA Travel Vaccine Market was valued at USD 49.22(Revenue in USD Million) in 2022.
RoMEA Travel Vaccine Market is projected to grow at a CAGR of 6.37% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the RoMEA Travel Vaccine Market, holding a largest market share of 40.97 USD Million in 2024
RoMEA Travel Vaccine Market Scope
RoMEA Travel Vaccine Market Segmentation & Scope
Disease
- COVID-19
- Others
- Polio
- Malaria
- Tick-Borne Encephalitis
- Measles and Mumps
- DPT
- Rabies
- Yellow Fever
- Meningococcal Meningitis
- Japanese Encephalitis
- Influenza
- Varicella
- Cholera
- Hepatitis
- Typhoid
Category
- Required Vaccine
- Routine Vaccine
- Recommended Vaccine
Distribution Channel
- B2C
- B2B
Age Group
- Above 50 Years
- Less than 20 Years
- 20-50 Years
Patient Type
- Geriatric
- Pediatric
- Adult
Gender
- Female
- Male
Route of Administration
- Oral
- Injectable
Type
- Viral Vector Vaccines
- DNA Vaccines
- Toxoid Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide and Conjugate Vaccines
- Inactivated Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Frequently Asked Questions
The RoMEA Travel Vaccine Market is segmented based on Segmentation Disease,Category,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Type,Composition.
RoMEA Travel Vaccine Market was valued at USD 49.22(Revenue in USD Million) in 2022.
RoMEA Travel Vaccine Market is projected to grow at a CAGR of 6.37% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Travel Vaccine Market for final year is USD 72.99 (USD Million).
RoMEA Travel Vaccine Market Company Profiling
Frequently Asked Questions
The RoMEA Travel Vaccine Market is segmented based on Segmentation Disease,Category,Distribution Channel,Age Group,Patient Type,Gender,Route of Administration,Type,Composition.
RoMEA Travel Vaccine Market was valued at USD 49.22(Revenue in USD Million) in 2022.
RoMEA Travel Vaccine Market is projected to grow at a CAGR of 6.37% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Travel Vaccine Market for final year is USD 72.99 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.